Results 251 to 260 of about 333,510 (359)

IRF8 Drives Conventional Type 1 Dendritic Cell Differentiation and CD8+ T Cell Activation to Aggravate Abdominal Aortic Aneurysm Development

open access: yesAdvanced Science, EarlyView.
This study highlights the critical role of IRF8 in the development of AAA. IRF8 activation promotes the differentiation of cDC1s, which in turn recruit and activate CD8+ T cells, contributing to aortic wall degradation. The study identifies the IRF8‐cDC1‐CD8+ T cell axis as a key pathway in AAA progression, offering new potential therapeutic targets to
Zhen Yuan   +11 more
wiley   +1 more source

Construction of multi-targeted CRISPR libraries in tomato to overcome functional redundancy at genome-scale level. [PDF]

open access: yesNat Commun
Berman A   +13 more
europepmc   +1 more source

CRISPR-Cas and restriction–modification systems are compatible and increase phage resistance [PDF]

open access: bronze, 2013
Marie-Ève Dupuis   +3 more
openalex   +1 more source

Getting Into the Rhythm With CRISPR [PDF]

open access: yesCirculation Research, 2018
Thierry Vandendriessche   +2 more
openaire   +3 more sources

Model‐Guided Rational Construction of Escherichia coli Synthetic Consortia for Enhanced 2‐Methylbutyric Acid Production

open access: yesAdvanced Science, EarlyView.
We developed a citramalate‐derived pathway for 2‐methylbutyric acid production in E. coli mono‐culture and consortia. The optimized consortium, using 2‐keto‐3‐methylvalerate as a node, achieved 1817.03 ± 103.73 mg L−1 2‐methylbutyric acid, a 28‐fold increase from the initial strain, with a yield of 0.091 g/g glucose.
Yu Liu   +3 more
wiley   +1 more source

Generating rats with conditional alleles using CRISPR/Cas9 [PDF]

open access: bronze, 2013
Yuanwu Ma   +8 more
openalex   +1 more source

COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma

open access: yesAdvanced Science, EarlyView.
COPS5, which is overexpressed in HCC in an amplification‐ and ATF4‐dependent manner, stabilizes MK2 through deubiquitination and, in turn, induces HSPB1 activation, protecting HCC cells from ferroptosis and thus promoting sorafenib resistance and tumor progression. Abstract Sorafenib, which is proven to serve as a potent ferroptosis inducer, is used as
Ai‐Ling Luo   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy